Results 41 to 50 of about 1,565 (185)
Pharmacokinetics of anti-infective agents during CytoSorb hemoadsorption
Cytokine hemoadsorption might be beneficial in patients with sepsis. However, its effect on anti-infective agents' disposition remains largely unknown.
Antoine G. Schneider +6 more
doaj +1 more source
BackgroundThere is a lack of data to support the use of hemoadsorption in pediatric septic shock. The aim of our study was to assess the effectiveness and safety of CytoSorb therapy in this setting.MethodsPhase II interventional single arm pilot study in
Gabriella Bottari +8 more
doaj +1 more source
Role of Hemoperfusion With HA330 in the Management of Severe Dengue Shock Syndrome. [PDF]
Introduction Infection‐associated hemophagocytic syndrome (IAHS) is a rare complication in dengue infection that leads to multiple organ dysfunction (MOD) and increased mortality rates. The early use of hemoperfusion with hemoadsorption and standard treatment may reduce inflammation and prevent mortality.
Virojtriratana T +2 more
europepmc +2 more sources
Immunomodulation by hemoadsorption [PDF]
Background: Sepsis is often associated with liver dysfunction, which is an indicator of poor outcomes. Specific diagnostic tools that detect hepatic dysfunction in its early stages are scarce. So far, the immune modulatory effects of hemoadsorption with \(CytoSorb^{®}\) on liver function are unclear.
Praxenthaler, Janina +6 more
openaire
Hemoadsorption in Patients with Various Types of Respiratory Support for Severe COVID-19
Study aim. To evaluate the efficacy of hemoadsorption in patients with severe COVID-19 on mechanical lung ventilation (MLV) and noninvasive respiratory support.Material and methods.
R. E. Yakubtsevich, D. N. Rakashevich
doaj +1 more source
Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review
COVID-19 has been affecting the world unprecedentedly and will remain widely prevalent due to its elusive pathophysiological mechanism and the continuous emergence of new variants.
Kaixi Chang +11 more
doaj +1 more source
Background and Objectives: The hemoadsorption device CytoSorb® (CytoSorbents Inc., Princeton, NJ, USA) has been shown to efficiently remove ticagrelor from whole blood in vitro.
Helmut Mair +7 more
doaj +1 more source
Advances in Research and Application of Bio-based Microsphere Adsorbents in Blood Adsorption
One of the key components of adsorbents for blood purification is the microsphere adsorbent. Microsphere adsorbents should meet the following requirements: stable physical and chemical structures, easy for functional modification to endow the adsorbents ...
Xinran GUO +5 more
doaj +1 more source
COVID-19: Hyperinflammatory Syndrome and Hemoadsorption with CytoSorb [PDF]
Following the emergence of a novel coronavirus from Wuhan, China, the world faced a major problem, so many countries were shocked by the outbreak of this virus. Unlike the rest of its dangerous family, it has a higher reproductive number than Middle East respiratory syndrome, which is estimated to be approximately 3.28 with a median of 2.79 and IQR of ...
Behnam, Masmouei +3 more
openaire +2 more sources
Critically ill patients are at risk of developing acute liver dysfunction as part of multiorgan failure sequelae. Clearing the blood from toxic liver-related metabolites and cytokines could prevent further organ damage.
Caner Turan +8 more
doaj +1 more source

